End Point Assessment

VJ Vanessa Bedoya Joaqui
NG Nathalia Buitrago Gómez
RO Reinaldo Carvajal Ortiz
LT Luis Miguel Osorio Toro
JL Jenny Patricia Muñoz Lombo
CC Carlos Alberto Salgado Cifuentes
MG Mónica Andrea Morales García
AL Alín Abreu Lomba
request Request a Protocol
ask Ask a question
Favorite

The primary endpoint was the mean change in HbA1c, from baseline to week 52. Secondary endpoints regarding glycemic control included the proportion of patients who reached an HbA1c target of less than 7% by week 52, and the mean change in FPG from baseline to week 52. Secondary endpoints in the assessment of cardiovascular risk factors included the change in systolic and diastolic BP and change in body weight from the beginning of the study to week 52.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A